Medicine Overview of Glimestar-M Tablet SR
Hypoglycemia (low blood sugar level), Altered taste, Nausea, Diarrhoea, Stomach pain, Headache, Upper respiratory tract infection.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Glimestar-M 4 Tablet is to be taken with food.
Glimestar-M 4 Tablet may cause stomach upset if taken empty stomach.
Glimestar-M 4 Tablet is a combination of two antidiabetic medicines: Glimepiride and Metformin. Glimepiride is a sulfonylurea which works by increasing the amount of insulin released by the pancreas in order to lower the blood glucose. Metformin is a biguanide which works by lowering glucose production in the liver, delaying glucose absorption from intestines and increasing the body's sensitivity to insulin.
In Depth Information on Glimestar-M Tablet SR
Glimestar-M Tablet SR related warnings
Taking metformin with alcohol can cause lactic acidosis and you may experience malaise, respiratory distress, slow or irregular heartbeat, sleepiness, stomach upset, or other unusual symptoms.
WEIGH RISKS VS BENEFITS
Glimestar-M 4 Tablet may be unsafe to use during pregnancy.
Animal studies have shown adverse effects on the foetus, however, there are limited human studies. The benefits from use in pregnant women may be acceptable despite the risk. Please consult your doctor.
Glimestar-M 4 Tablet is probably safe to use during lactation.
Limited human data suggests that the drug does not represent a significant risk to the baby.
Your ability to drive may be affected if your blood sugar is low or high. If this happens, do not drive.
Glimestar-M 4 Tablet should be used with caution in patients with kidney disease. Dose adjustment of Glimestar-M 4 Tablet may be needed. Please consult your doctor.
Use of Glimestar-M 4 Tablet is, however, not recommended in patients with severe kidney disease. Regular monitoring of kidney function test is advisable while you are taking this medicine.
Glimestar-M 4 Tablet should be used with caution in patients with liver disease. Dose adjustment of Glimestar-M 4 Tablet may be needed. Please consult your doctor.
Glimestar-M 4 Tablet is generally started with low dose in patients with mild to moderate liver disease and its use is not recommended in patients with severe liver disease.
No Patient Concerns found for this medicine
User Submitted Feedback For Glimestar-M 4 Tablet
Patients taking Glimestar-M 4 Tablet What were the side-effects while using Glimestar-M 4 Tablet? How do you take Glimestar-M Tablet SR? How much was the improvement? What are you using Glimestar-M Tablet SR for?
Survey Participants: 1
“The following are the results of on-going survey on 1mg.com for Glimestar-M 4 Tablet. These results only indicate the perceptions of the website users. Please base your medical decisions only on the advice of a doctor or a registered medical professional.”
One of the following vendor pharmacies will deliver Glimestar-M 4 Tablet: HZF, BLE, NWP, QLF, GTK, EMB, BHS, RKS, GBL, OWP, RHL, SRG, JVO, RPI, MAK, PLT, 9T9, SGH, OIP, ATL, RUS, THP, STA, BLS, RHW, WSI, NSL, MDH, PTI, PVP, ABP, JBT, GHR, ADT, DAO, DVH, OHM, AYU, SVS, BHM, MAP, RSA, NDP, DFP, LHA, JHC, VJS, ENP, AVS, MPC, SDM, SVH, P2P, RDR, SBA, SGC, HIP, SMN, ATP, ZEL, MAM, MSD, SCH, BMJ, ESY, RDH, BTM, HTS, AGT, AAY, DHP, BAP, TOM, KMC, EPS, EVP, CLT, RPP, JSL, UBL, TFP, DHR, HNP, JVN, NNH, UMP, IAD, HPC, BDN, VNS, GNC, USF, HSP, NAS, RJH, FGH, SYN, JIV, WHL, KHH, NVL, PMA, HMP, PEN, BAL, RWP, DYG, PRN, RSS, QTM, LCC, DPP, MLC, LMS, INC, VRS, SSA, GPT, SHD, SBL, PNT, BGS, NTB, NNP, SPD, SWA, DGN, ANT, MMS, NVY, PPR, KHC, SAF, TNH, BHP, HBV, HAT, HGI, BSN, AYM, NXG, ZPR, PWN, SWP, SHC, GTC, VDH, OLT, MDO, SLN, DZY, AAR, EQN, GPP, TRP, ARD, ZVP, AMR, KIS, BBS, SJP, AWS, BIO, CHP, HEX, MAX, IPL